Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
The new drugs must be used within a narrow window of time after developing symptoms.
Molnupiravir reduces severe illness and death, but it must be started within days after developing symptoms.
Post-exposure and pre-exposure prophylaxis could be a game-changer for immunocompromised people.
People under 50 who were cured of hepatitis C were at comparable risk to the general population.
The government-wide effort aims to develop the next generation of COVID-19 treatments to prepare the U.S. to respond to future virus threats
Positive diagnostic tests and drug prescriptions dropped 40% in July 2020 compared with earlier years.
Suppression of hepatitis B virus with antiviral treatment lowered the risk of hepatocellular carcinoma by 58%.
Assessing patient-reported outcomes can support treatment for hard-to-reach populations.
People who received treatment had a lower composite risk of cirrhosis, liver cancer and death.
The risk was lower in people who had achieved a sustained virological response compared with those who had not.
No significant links were found between liver stiffness prior to antiviral treatment and cirrhosis, liver cancer or transplants or death.
Mental health professionals should take a more active role in the HCV treatment arena.
New app allows people living with HCV to take part in a research study aimed at tracking antiviral medication effects.
Promising results in studies are tempered by myriad barriers against successfully treating and curing the disease in real world settings.
A recent study suggests that hepatitis C virus (HCV) antiviral treatment may prevent liver cancer in people with HCV, nearly cutting in half t...
Squalamine, an immune agent discovered in sharks and later synthesized in the laboratory, looks to have unusual antiviral properties
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.